Doxycycline-based first-line quadruple therapy:: Benefit of H. pylori eradication in children

被引：0
|
作者：
Nijevitch, A. A.
Akhmadeyeva, E. N.
Nasretdinova, E. K.
Sataev, V. U.
机构：
来源：
HELICOBACTER | 2008年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：447 / 447
页数：1
相关论文
共 50 条
  • [1] How effective are quadruple therapies as first-line H. pylori eradication therapies?
    Thomas J Borody
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (4): : 174 - 175
  • [2] A Retrospective Study of Doxycycline-Based Quadruple Therapy versus Tetracycline-Based Quadruple Therapy for the First Line Treatment of Helicobacter pylori
    Meader, Ryan
    Wichelmann, Thomas A.
    Kruchko, David H.
    Shapiro, Alan
    Ehrenpreis, Eli
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1148 - S1148
  • [3] Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study
    De Francesco, Vincenzo
    Pontone, Stefano
    Bellesia, Annamaria
    Serviddio, Gaetano
    Panetta, Cristina
    Palma, Rossella
    Zullo, Angelo
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : 139 - 141
  • [4] Levofloxacin, amoxicillin and omeprazole as first-line triple therapy for H. pylori eradication
    Gisbert, J. P.
    Fernandez-Bermejo, M.
    Molina-Infante, J.
    Perez-Gallardo, B.
    Prieto-Bermejo, A.
    Mateos-Rodriguez, J.
    Robledo-Andres, P.
    Gonzalez-Garcia, G.
    [J]. HELICOBACTER, 2008, 13 (05) : 460 - 461
  • [5] Recent eradication rate of first-line triple therapy for H. pylori in Korea
    Lim, Y. J.
    Park, J. B.
    Lee, J. H.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A122 - A122
  • [6] Selecting the Optimum First-line Treatment for H. pylori Eradication
    Ang, Tiing L.
    Almadi, Majid A.
    [J]. SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (04): : 183 - 184
  • [7] The Trend of Eradication Rates of First-Line Therapy and Second-Line Quadruple Therapy Containing Metronidazole for H. pylori Infection for Recent Five Years
    Park, J.
    Park, S.
    Kim, G.
    Seoul, S.
    Moon, J.
    Jee, S.
    Jung, H.
    Lee, D.
    Kim, J.
    Lee, S.
    [J]. HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [8] A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study
    De Francesco, Vincenzo
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (01) : 129 - 130
  • [9] Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study
    Ergul, Bilal
    Kocak, Erdem
    Tas, Adnan
    Filik, Levent
    Koklu, Seyfettin
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (05) : 527 - 529
  • [10] EFFICACY OF CONCOMITANT NONBITHMUTH-BASED QUADRUPLE THERAPY AS FIRST-LINE TREATMENT FOR ERADICATION OF HELICOBACTER PYLORI
    Moon, B.
    Lim, H.
    Lee, S.
    Han, K.
    Chung, J.
    Lee, Y.
    [J]. HELICOBACTER, 2011, 16 : 131 - 132
12345